PHYTOCHEMISTRY, PHARMACOLOGY, NUTRITIONAL COMPOSITION, AND ETHNOMEDICINAL SIGNIFICANCE OF JATROPHA TANJORENSIS (HOSPITAL TOO FAR) LEAVES: A SCOPING REVIEW

Authors

  • Barnabas Oluwatomide Oyeyinka Biomedicinal Research Centre, Forestry Research Institute of Nigeria, Ibadan,
  • David Udosinachi Okwor Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka (UNN),
  • Emeka Jesse Onyebueke Department of Public Health, Faculty of Basic and Applied Biological Sciences, Ahmadu Bello University, Zaria, Kaduna State,
  • Muhammed Adewale Alimi Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Usmanu Danfodiyo University, Sokoto,
  • Sidiqot Opeyemi Abdulrasaq Department of Chemistry and Industrial Chemistry, Faculty of Pure and Applied Sciences, Kwara State University, Malete,
  • Obianuju Perpetua Metu Postgraduate Program in Genetics, Biodiversity and Conservation, Faculty of Biological Science, Universidade Estadual do Sudoeste da Bahia (UESB), Bahia,

Abstract

Jatropha tanjorensis J.L. Ellis & Saroja (Euphorbiaceae), popularly known as hospital too far in Nigeria, is a leafy vegetable and an ethnomedicinal plant traditionally used for anaemia, diabetes, and malaria. This scoping review maps evidence on the phytochemistry, pharmacology, toxicology, nutritional composition, and ethnomedicinal significance of J. tanjorensis leaves. Following the Arksey and O'Malley framework and PRISMA-ScR guidelines, 43 peer-reviewed sources were identified through PubMed, Google Scholar, ScienceDirect, AJOL, Scopus, and Web of Science. Flavonoids, tannins, saponins, terpenoids, steroids, and cardiac glycosides are consistently reported. GC-MS and LC-MS/MS chemical elucidations identified over 50 compounds, including phytol, benzenetriol derivatives, and flavonoid glycosides. Preclinical evidence documents anti-anaemic, hepatoprotective, antimicrobial, antidiabetic, and antimalarial activities, but antioxidant potency is weak and variable, and reproductive activity findings are directly contradictory, as no human clinical trials were identified. The ethnopharmacological evidence base of J. tanjorensis is heterogeneous and exclusively preclinical. Standardized assay protocols, dose-response studies, and human trials are priorities.

Downloads

Published

2026-10-04

Issue

Section

ARTICLES